FeesSafety
Pluang+

NRx completes validation and confirms 2-year stability for preservative-free ketamine ahead of FDA approval

Market News
19 Oct 2026, 15:30 WIB
GlobeNewsWire
View Source
Bullish
NRx completes validation and confirms 2-year stability for preservative-free ketamine ahead of FDA approval

NRx Pharmaceuticals has successfully completed the manufacturing process validation for preservative-free ketamine and confirmed two-year stability data showing the drug remains potent and sterile without preservatives. This milestone prepares NRx to supply the drug immediately upon FDA approval expected by November 10, 2026. The drug addresses shortages and has potential for treating suicidal ideation in depression. NRx aims for a labeled shelf life of three years or more, enhancing availability for hospitals and clinics.

NRx Pharmaceuticals' recent manufacturing milestone for preservative-free ketamine provides context for readers. For those tracking the health sector, as of Oct 19, 2026 18:43 WIB, 68 of 150 US health stocks on Pluang rose while 54 fell. Among notable movers, IOVA gained 1.32% to USD 13.80 with a typical hold time of 2 days, SANA also rose 1.32% to USD 2.30 with a 24-day hold, whereas SNY declined 1.28% to USD 40.09 with a much longer hold time of 94 days.

More News

Siemens beats earnings estimates and raises medium-term guidance on strong smart infrastructure growth

Siemens beats earnings estimates and raises medium-term guidance on strong smart infrastructure growth

Siemens reported earnings per share of $1.62 and revenue of $26.28 billion, both exceeding analyst expectations. The company saw record orders and double-digit revenue growth in its smart infrastructure and digital industries units, prompting it to r...

Company Fundamentals
Bullish
2 hours ago
ASUS launches AI-ready hardware and software for gamers, creators, and enterprises with local, cloud, and hybrid AI options.

ASUS launches AI-ready hardware and software for gamers, creators, and enterprises with local, cloud, and hybrid AI options.

ASUS has introduced a broad ecosystem of AI-ready hardware and software designed for gamers, creators, developers, and enterprises. The ASUS Agent Computer initiative enables users to deploy AI locally, in the cloud, or via hybrid models, offering co...

Market News
Bullish
2 hours ago
Cosmetic peptide synthesis market to reach $355M by 2032, driven by anti-aging skincare demand and tech advances.

Cosmetic peptide synthesis market to reach $355M by 2032, driven by anti-aging skincare demand and tech advances.

The global cosmetic peptide synthesis market is projected to grow from $274 million in 2027 to $354.85 million by 2032, with a CAGR of 5.34%. Growth is fueled by rising demand for advanced anti-aging skincare ingredients, increased use of peptide-bas...

Market News
Bullish
2 hours ago
Cisco Q1 2027 earnings focus on cloud and AI with revenue expected at $18.1B and EPS $1.33

Cisco Q1 2027 earnings focus on cloud and AI with revenue expected at $18.1B and EPS $1.33

Cisco is set to report its fiscal Q1 2027 earnings with a focus on cloud growth and AI demand. Analysts expect revenue around $18.1 billion, operating income of $6.5 billion, and earnings per share of $1.33, reflecting strong year-over-year growth. T...

Company Fundamentals
Neutral
2 hours ago
BASF to sell its mining solutions business to SNF, deal expected to close in 2027.

BASF to sell its mining solutions business to SNF, deal expected to close in 2027.

BASF has agreed to sell its global mining solutions business to SNF, a specialty chemical company based in France, following a strategic review of BASF's Performance Chemicals division. The deal includes BASF's mining chemicals portfolio, production ...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App